High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$63.1M
$63,132,521
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| KRYS |
Krystal Biotech, Inc.
|
CEO
10b5-1 Sell
|
2026-03-04 | $6,579,164Whalex10 | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
President
10b5-1 Sell
|
2026-03-04 | $6,580,270Whalex10 | S | Form 4 |
|
KRYS
S
Krystal Biotech, Inc.
ROMANO KATHRYN
• Officer • Chief Accounting Officer
10b5-1 Sell
2026-03-02
$200,700
|
||||||
| KRYS |
Krystal Biotech, Inc.
|
Officer • Chief Accounting Officer
10b5-1 Sell
|
2026-03-02 | $200,700 | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
Director
10b5-1 Sell
|
2026-02-27 | $3,252,824Largex2 | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
Director
10b5-1 Sell
|
2026-02-26 | $2,133,679Largex2 | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
Director
10b5-1 Sell
|
2026-02-25 | $192,500 | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
Director
10b5-1 Sell
|
2026-02-24 | $13,823,204MEGAx17 | S | Form 4 |
|
KRYS
S
Krystal Biotech, Inc.
ROSSI DINO A
• Director
Discretionary Sell
2026-02-19
$4,953,694Largex2
|
||||||
| KRYS |
Krystal Biotech, Inc.
|
Director
Discretionary Sell
|
2026-02-19 | $4,953,694Largex2 | S | Form 4 |
|
KRYS
S
Krystal Biotech, Inc.
ROMANO KATHRYN
• Officer • Chief Accounting Officer
10b5-1 Sell
2026-02-09
$3,401,705Largex7
|
||||||
| KRYS |
Krystal Biotech, Inc.
|
Officer • Chief Accounting Officer
10b5-1 Sell
|
2026-02-09 | $3,401,705Largex7 | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
CEO
10b5-1 Sell
|
2025-12-04 | $11,007,447MEGAx16 | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
President
10b5-1 Sell
|
2025-12-04 | $11,007,333MEGAx16 | S | Form 4 |